Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer
Status:
Terminated
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Cyproheptadine hydrochloride may help improve appetite and lessen weight loss
caused by cancer or cancer treatment. It is not yet known whether cyproheptadine
hydrochloride is more effective with or without nutritional supplementation in improving
weight and quality of life of young patients with weight loss caused by cancer or cancer
treatment.
PURPOSE: This randomized phase II trial is studying cyproheptadine hydrochloride to see how
well it works when given together with or without nutritional supplementation in treating
young patients with weight loss caused by cancer or cancer treatment.